Perimenopause can change the ADHD experience in ways that are easy to miss.
A new 2026 review examining ADHD treatment during perimenopause, menopause, and post-menopause highlights an issue that deserves much more attention: changing estrogen levels may intensify ADHD symptoms and, for some women, may make their usual ADHD treatment feel less effective.
This matters because the overlap between ADHD and menopause can be significant. Brain fog/forgetfulness, low motivation, emotional changes, sleep disruption, and problems with executive functioning can all show up during the menopausal transition. When someone already has ADHD, it can become difficult to untangle what’s related to their longstanding neurodevelopmental condition and what’s being influenced by hormonal changes.
And there’s another layer. Many women have spent years developing strategies to compensate for their ADHD. They may have created highly structured routines, relied heavily on calendars and reminders, overprepared, worked longer hours, or simply pushed themselves harder to keep up. When hormonal changes affect attention, energy, emotional regulation, or executive functioning, those strategies may suddenly stop being enough.
Therapy can help women understand what’s changing, identify patterns in their symptoms and functioning, and separate difficulty from shame. It can also create space to rethink expectations, build systems around current capacity rather than past capacity, and develop more sustainable ways of managing executive functioning and emotional regulation.
It’s equally important for therapists to recognize when a client may benefit from medical assessment. The review points out that research specifically examining ADHD medication in menopausal women is still limited, so treatment decisions need to be individualized. Collaboration between therapists, prescribers, and healthcare providers can be especially valuable during this stage, highlighting the importance of wraparound care.